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Background: Impaired thermogenesis can promote obesity. Therefore, the aim of this study was to investigate
whether the expression of thermogenesis-related genes is altered in adipose tissues of obese individuals and
whether excessive methylation of their promoters is involved in this phenomenon.
Methods: The expression of genes encoding β adrenergic receptors (ADRBs), thyroid hormone receptors (THRs),
5’-iodothyronine deiodinases (DIOs), and uncoupling proteins (UCPs) was measured by real-time PCR in visceral and
in subcutaneous adipose tissues of 58 obese (BMI >40 kg/m2) and 50 slim (BMI 20-24.9 kg/m2) individuals. The
methylation status of these genes was studied by the methylation-sensitive digestion/real-time PCR method.
Results: The expression of ADRB2, ADRB3, THRA, THRB, DIO2, UCP2 was significantly lower in the adipose tissues of
obese patients than in tissues of normal-weight individuals (P < 0.00001). In the obese, the expression of ADRB2,
ADRB3, DIO2 was lower in visceral adipose tissue than in subcutaneous adipose tissue (P = 0.008, P = 0.002, P = 0.001,
respectively). However, the mean methylation of CpG islands of these genes was similar in tissues with their high
and low expression, and there was no correlation between the level of expression and the level of methylation.
Conclusions: Decreased expression of thermogenesis-related genes in adipose tissues of obese patients might
result in the reduced reactivity to both hormonal and adrenergic stimuli and therefore in a lower potential to
activate thermogenesis.
Keywords: Obesity, Adrenergic receptors, Thyroid hormone receptors, 5’-iodothyronine deiodinases, Uncoupling
proteins, MethylationBackground
The imbalance between energy intake and expenditure is
one of the main causes of obesity [1]. Since most of the
currently available non-invasive obesity treatments are
ineffective in the long-term, new therapeutic strategies
need to be developed to reduce excessive adiposity [2].
In small mammals and in human newborns, non-
shivering thermogenesis in brown adipose tissue (BAT)
is the most important regulatory mechanism for main-
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unless otherwise stated.however that BAT cells dispersed within the white adi-
pose tissue (WAT), also known as beige/brite adipocytes,
co-regulate energy homeostasis and their number in-
creases upon exposure to cold also in adult organisms
[4,5]. Thermogenic function of brown adipocytes is
under strict neurohormonal control. Exposure to cold
leads to increased noradrenaline release and subsequent
stimulation of various subtypes of β-adrenergic receptors
(ADRB), leading to the proliferation of brown adipocytes
(ADRB1) [6] and activation of lipolysis and/or of
thermogenesis (ADRB2 and ADRB3) [7]. While adrener-
gic stimulation provides the means for rapid responses,
triiodothyronine (T3) increases the capacity of cells to
respond to catecholamines [8,9]. Moreover, cold-induced
noradrenergic stimulation of brown adipocytes results intral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nase (DIO2), which catalyzes conversion of thyroxin
(T4) to T3 [10]. Subsequently, T3 acting by its α and β
nuclear receptors (TRα and TRβ, respectively) increases
the expression of various genes, including the genes for
uncoupling proteins (UCP) responsible for dissipation of
oxidation energy as heat in BAT’s mitochondria [11,12].
There is mounting evidence that disturbances of
thermogenesis-related pathways may play a role in the
development of obesity. Early epidemiological studies
showed that obese individuals have lower energy ex-
penditure; this could be explained by a lower efficiency
of adaptive thermogenesis [13]. To verify this hypothesis,
a number of animal knock-outs with a selective ablation
of various thermogenesis-related genes were created;
however, results of these studies were ambiguous and
underlined the complexity of mechanisms controlling
thermogenesis [14-18]. Studies concerning the use of
various activators of thermogenesis in the treatment of
obesity were also performed, and a number of novel
thermogenic compounds are currently being studied,
such as synthetic and selective thyroid hormone receptor
or β-adrenergic receptor agonists [19].
In recent years, epigenetic modifications, activated via
environmental stimuli, has been found to be an important
mechanism regulating the gene expression in adipocytes.
For example, it was shown that in mouse pre-adipocytes,
a high-fat diet promotes methylation of the peroxisome
proliferator-activated receptor γ (PPARG) promoter and
this may contribute to the pathogenesis of obesity and of
the metabolic syndrome [20]. Diet deficient in methyl
group donors and methionine-homocysteine cycle co-
factors (e.g. folate, methionine, choline, betaine) reduces
methylation and up-regulates the expression of genes in-
volved in free fatty acids uptake and in synthesis of triglyc-
erides, promoting fatty-liver disease and, presumably,
obesity [21]. In human adipose tissue, even moderate cal-
orie restriction decreases methylation of the cholesterol
ester transfer protein gene resulting in its higher expres-
sion; this facilitates lipid transport to cellular sites where
hydrolytic enzymes are active [22]. Therefore, it is
plausible that epigenetic modifications regulate the
equilibrium between the environment and the activity
of thermogenesis-related genes. This is supported by
the results of animal studies showing that the expres-
sion of these genes depends on environmental factors
such as diet or exposure to cold (14-17).
So far little is known about the physiological changes in
thermogenesis-related pathways in adipose tissue of obese
humans, and such knowledge would constitute a crucial
link between the in vitro experiments and pharmaco-
logical studies. In this work we show that the expression
of several thermogenesis-related genes is lower in adipose
tissues originating from obese individuals than in tissuesof non-obese study participants, and that the level of ex-
pression of these genes is probably not related to the
methylation status of their promoters.
Methods
Adipose tissue
One hundred sixteen samples of visceral (VAT) and sub-
cutaneous (SAT) adipose tissues were obtained from 58
obese patients (body mass index (BMI) calculated as
weight (kg) divided by height squared (m2), >40 kg/m2)
during bariatric surgery. Fifty control tissues were col-
lected from normal-weight patients (BMI 20-24.9 kg/m2)
undergoing elective cholecystectomy (VAT, N = 22) or
operated on for inguinal hernia (SAT N = 28). After col-
lection, the samples were immediately frozen in liquid
nitrogen and stored at -80°C. The project was approved
by the Bioethics Committee of the Medical University of
Warsaw (decision KB/47/2009), and a written informed
consent for participation in this study was obtained from
all participants.
Basic biochemical parameters
Basic biochemical and hormonal parameters in serum/
plasma of obese individuals were measured in the diag-
nostic laboratory of the Infant Jesus Teaching Hospital
of the Medical University of Warsaw, according to a
routine procedure.
Nucleic acids isolation, reverse transcription and real-time
PCR
Approximately 500 mg of each tissue was homogenized in
liquid nitrogen and total RNA and DNA were extracted
with TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) ac-
cording to the manufacturer’s procedure. One hundred
nanograms of each RNA was used for reverse transcrip-
tion performed with RevertAid First Strand cDNA Syn-
thesis Kit (Fermentas, Vilnius, Lituania) according to the
manufacturer’s protocol. The resulting cDNA was diluted
in RNAse-free dH2O (Invitrogen, Carlsbad, CA, USA).
Next, 1 μl of cDNA corresponding to 0.5 ng of total RNA
was used as a template in real-time PCR performed in
LightCycler 480 Instrument II (Roche, Mannheim,
Germany) with LightCycler 480 Sybr Green I Master Kit
(Roche, Mannheim, Germany) and with specific primers
(Additional file 1: Table S1). The PCR conditions were as
follows: initial incubation at 95°C for 10 min, 40 cycles of
95°C for 12 s, 58-62°C for 12 s, 72°C for 12 s, and then
one melting curve cycle. All measurements were per-
formed in triplicate. The results were normalized against
the results for the β-actin gene (ACTB) and presented in
arbitrary units (AU) as mean mRNA levels, as well as the
mean expression Fold Change (FC = 2-ΔΔCt), considering
that FC is significant if < -1.50 (down-regulation) or >1.50
(up-regulation).
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Analysis of methylation was performed with the One-
Step qMethyl Kit (Zymo Research, Irvine, CA, USA) ac-
cording to the manufacturer’s protocol. The tested DNA
was divided into a “test reaction” and a “reference reac-
tion”. Each sample contained 20 ng of the genomic
DNA, 10 μl of 2x Test/Reference Reaction Premix and
1 μl of 10 μM solution of the primers (Additional file 2:
Table S2). The test sample was then digested with a mix
of methylation sensitive restriction enzymes (AccII,
HpaII, HpyCHIV4) at 37°C for 2 hours, while the refer-
ence sample was not. Subsequently, the DNA from both
samples was amplified in the LightCycler 480 Instru-
ment II in the presence of SYTO® 9 fluorescent dye and
then quantified. The PCR conditions were as follows: de-
naturation at 95°C for 10 min, 45 cycles of 95°C for 30 s,
62-64°C for 60 s, 72°C for 60 s, and then one melting
curve cycle. All measurements were performed in dupli-
cate. Along with the patients’ samples, Human Methyl-
ated & Non-methylated DNA Standards provided by the
manufacturer were also tested in order to validate the
quality of the reactions. The methylation level of the
amplified region was determined using the following
equation: percent methylation = 100 × 2-ΔCt, where ΔCt
is the average Ct value from the test reaction minus the
average Ct value from the reference reaction.Table 1 Selected clinical and biochemical parameters of study
Obese individuals
Mean ± SD
Age (years) 41.45 (±10.18)
Weight (kg) 131.98 (±17.72)
BMI (kg/m2) 46.93 (±4.77)
Adipose tissue (% body mass) 48.08 (±4.95)
Waist circumference (cm) 123.24 (±18.34)
CRP (nmol/l) 95.6 (±44.1)
Glucose (mmol/l) 5.57 (±1.47)
Total cholesterol (mmol/l) 5.21 (±1.54)
LDL (mmol/l) 3.26 (±1.03)
HDL (mmol/l) 1.22 (±0.24)
Triglycerides (mmol/l) 1.70 (±1.36)
TSH (IU/l) 1.70 (±0.85)
FT4 (pmol/l) 13.82 (±3.13)
FT3 (nmol/l) 2.85 (±1.01)
Co-morbidities
Type 2 DM/IGT 26 (44.83%)
Hypertension 35 (60.34%)
Hyperlipidemia 36 (62.09%)
BMI: body mass index calculated as weight (kg) divided by height squared (m2), LD
protein, TSH: thyroid stimulating hormone, FT4: free thyroxin, FT3: free triiodothyronStatistical analysis
The differences in mRNA expression were assessed with
the Statistica software package v.10 (StatSoft, Tulsa, OK)
using the Student’s t/Mann-Whitney U test or Kruskal-
Wallis analysis of variance. All correlations between
quantitative values were performed with the Spearman
correlation test. Normality of distribution and homogen-
eity of the variance were checked with the Shapiro-Wilk
and Levene’s tests, respectively. To minimize false posi-
tives, the Bonferroni correction for multiple testing was ap-
plied and the level of significance was established at 0.01.
Results
Studied groups
The group of obese individuals consisted of 49 females
and 9 males. Their basic clinical characteristics, bio-
chemical parameters and thyroid status are summarized
in Table 1. The metabolic syndrome was diagnosed in 48
(82.7%) on the basis of the International Diabetes Feder-
ation criteria for the Europeans [www.idf.org]. All pa-
tients suffering from type 2 diabetes mellitus and with a
glomerular filtration rate (GFR) ≥60 ml/min were treated
with metformin or with a combination of metformin and
sulphonylureas, while individuals with GFR <60 ml/min
were treated only with sulphonylureas. Patients with
hypertension received at least one antihypertensive drugparticipants
Controls
Min-Max Mean ± SD Min-Max
20-59 44 (±14.1) 23-62
100-199.8 67 (±11.23) (50-90)
40.11-59.25 23.32 (±1.57) 20.1-24.9
32.64-57.23 -
97-167 -
11.4-184.7 26.19 (±18.1) (1.9-49.5)
3.22-10.16 4.99 (±0.41) (4.22-5.49)
3.13-7.86 5.04 (±0.23) (4.81-5.33)
1.24-5.64 2.74 (±0.13) (2.64-2.9)
0.77-1.79 1.63 (±0.39) (1.24-2.15)
0.52-7.62 1.29 (±0.17) (1.09-1.46)






L: low density lipoproteins, HDL: high density lipoproteins, CRP: C-reactive
ine, DM: diabetes mellitus, IGT: impaired glucose tolerance.
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receptor antagonist, diuretic, calcium channel blocker, or
β-blocker). Individuals diagnosed with hyperlipidemia
received statins or fibrates. All patients were euthyroid.
The control group consisted of 40 females and 10
males. Apart from cholelithiasis or inguinal hernia, they
had no history of any chronic disease, including compo-
nents of the metabolic syndrome and thyroid diseases.
Their normal health status was confirmed by physical
examination and blood tests (Table 1). Although their
adipose tissue content was not calculated, based on their
medical history, BMI values and biochemical parameters,
they were considered to be metabolically healthy.
A detailed dietary questionnaire was not obtained
from our study subjects; however, calculations based on
the typical menus showed that in obese individuals the
average daily calorie intake exceeded energy demand by
at least 1000-1500 kcal in women and by 1500-2000 kcal
in men. All obese individuals led a sedentary lifestyle.
Expression of thermogenesis-related genes in adipose
tissues from obese and from slim individuals
Ten genes were included into the study: ADRB1, ADRB2
and ADRB3 encoding adrenergic receptors β1, β2 and
β3, DIO1 and DIO2 encoding type 1 and type 2 5’-
iodothyronine deiodinases, THRA and THRB encoding
thyroid hormone receptors α and β, and UCP1, UCP2,
UCP3 encoding uncoupling proteins 1, 2 and 3. Initial
analysis showed that the mean expressions of these
genes did not differ in adipose tissues of males and fe-
males; therefore, all analyses were performed for both
sexes together.
Analysis of the expression of ADRB2 (Figure 1B) and
ADRB3 (Figure 1C) showed that their mean mRNA
levels were significantly lower in adipose tissues of obese
patients than in the tissues of normal-weight controls
(P < 0.00001 and P < 0.00001), both in VAT (P < 0.0001Figure 1 Comparison of the expression of ADRB1 (A), ADRB2 (B) and
adipose tissues of obese (O) and normal-weight (N) individuals. Result
mean ± standard deviation.for both) and in SAT (P = 0.0001 and P = 0.002, respect-
ively). Furthermore, in obese patients the mean expres-
sion of ADRB2 and ADRB3 was significantly lower in
VAT than in SAT (P = 0.008 and P = 0.002, respectively),
while in normal-weight individuals no difference be-
tween VAT and SAT was detected. The expression of
ADRB1 was similar in all examined tissues (Figure 1A).
The mean expression of DIO2 (Figure 2B) was signifi-
cantly lower in adipose tissues of obese patients than in
the control group (P < 0.0001), and the difference
concerned both VAT (P = 0.003) and SAT (P = 0.005). In
obese patients, the mean DIO2 expression was signifi-
cantly lower in VAT than in SAT (P = 0.001) and a simi-
lar observation was made in normal-weight individuals
(P = 0.005). No differences in the DIO1 expression were
observed in the investigated tissues (Figure 2A). The
mean expression of THRA (Figure 2C) was significantly
lower in adipose tissues of obese patients than in those
of normal-weight individuals (P < 0.0001), but the differ-
ence was detected only in VAT (P < 0.0001). In addition,
in obese patients the expression of THRA was similar in
VAT and SAT, while in normal-weight individuals it was
higher in VAT than in SAT (P = 0.004). The mean ex-
pression of THRB (Figure 2D) was significantly lower in
adipose tissues of obese patients than of normal-weight
individuals (P < 0.0001), and the difference concerned
both VAT (P = 0.007) and SAT (P = 0.003). The THRB
expression was similar in VAT and SAT of obese pa-
tients. It was also similar in both adipose tissue subtypes
of normal-weight individuals.
The mean expression of UCP2 (Figure 3B) was signifi-
cantly lower in adipose tissues of obese patients than in
normal-weight individuals (P < 0.0001), and the differ-
ence was noted in both VAT (P = 0.002) and SAT
(P = 0.009). The UCP2 expression did not differ between
VAT and SAT of obese patients and between VAT and
SAT of normal-weight individuals. The analysis of UCP1ADRB3 (C) genes in the visceral (VAT) and subcutaneous (SAT)
s, normalized against the expression of ACTB, are shown as the
Figure 2 Comparison of the expression of DIO1 (A), DIO2 (B), THRA (C), and THRB (D) genes in the visceral (VAT) and subcutaneous
(SAT) adipose tissues of obese (O) and normal-weight (N) individuals. Results, normalized against the expression of ACTB, are shown as the
mean ± standard deviation.
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mean mRNA levels between the investigated tissues
(Figures 3A, 3C).
Alternative analysis using the expression FC (Table 2)
confirmed the described above differences described
above in the ADRB2, ADRB3, DIO2, THRA, THRB and
UCP2 mRNA levels.Figure 3 Comparison of the expression of UCP1 (A), UCP2 (B), and of
adipose tissues of obese (O) and normal-weight (N) individuals. Result
mean ± standard deviation.The experiments were performed on the whole adi-
pose tissue homogenates. However, the finding that the
mean expression of two BAT-specific genes, UCP1 and
PPARG (Figure 3 and Additional file 3: Figure S1), was
similar in all analyzed tissues, implies that the differ-
ences in the expression of thermogenesis-related genes
were not due to a different content of beige adipocytes.the UCP3 (C) genes in the visceral (VAT) and subcutaneous (SAT)
s, normalized against the expression of ACTB, are shown as the
Table 2 Mean expression fold changes of thermogenesis-related genes in adipose tissues of obese and normal-weight
individuals
Gene name Gene description Gene Bank Mean expression fold change P*
VAT-O SAT-O VAT-N SAT-N
ADRB1 adrenergic receptor beta 1 NM_000684 1.48 1.44 1.49 1.42 NS
ADRB2 adrenergic receptor beta 2 NM_000024 0.97 1.70 2.10 3.81 P < 0.0001
ADRB3 adrenergic receptor beta 3 NM_000025 2.62 1.66 5.43 3.15 P < 0.0001
DIO1 5’-iodothyronine deiodinase type 1 NM_000792 0.7 0.87 1.38 1.40 NS
DIO2 5’-iodothyronine deiodinase type 2 NM_001007023 0.55 1.62 2.13 2.60 P < 0.0001
THRA thyroid hormone receptor α NM_003250 1.79 1.70 6.03 4.18 P < 0.0001
THRB thyroid hormone receptors β NM_000461 0.57 0.58 1.92 1.13 P < 0.0001
UCP1 uncoupling protein 1 NM_021833 1.13 1.27 1.43 1.49 NS
UCP2 uncoupling protein 2 NM_003355 1.79 1.30 5.10 3.64 P < 0.0001
UCP3 uncoupling protein 3 NM_003356 0.82 0.53 0.85 0.86 NS
*P values calculated with the Kruskal-Wallis analysis of variance.
N: normal-weight; O: obese; VAT: visceral adipose tissue; SAT subcutaneous adipose tissue; NS: not significant.
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related genes from adipose tissues of obese individuals
and clinical, biochemical as well as hormonal parameters
The expression levels of the investigated genes were corre-
lated with basic clinical (BMI, percentage of the adipose
tissue, waist circumference), biochemical (fasting serum
glucose, total cholesterol, low density lipoproteins, high
density lipoproteins, triglycerides and C-reactive protein
concentrations), as well as hormonal (thyroid stimulating
hormone, free thyroxin, free triiodothyronine) parameters.
No significant correlations were found.Methylation of the regulatory regions of thermogenesis-
related genes in adipose tissues
The analysis of the methylation status of genes of inter-
est was preceded by an in silico analysis of their regula-
tory regions with the CpG Islands Searcher (www.
cpgislands.com) and CpG Plot (http://www.ebi.ac.uk). In
five out of six genes with expression levels significantly
different in obese and slim individuals, namely in
ADRB2, ADRB3, THRA, THRB, and DIO2, the analysis
revealed the presence of CpG islands in their promoters.
Subsequently, 22 DNA samples for each gene, 11 repre-
senting tissues with a low, and 11 representing tissues
with a high expression of this gene were used for methy-
lation analysis. The mean level of methylation in tissues
with a low expression was similar to the level of methy-
lation in tissues with a high expression of each of these
genes. There was no correlation between the levels of
expression and methylation (Figure 4). In addition, the
mean level of methylation of each gene was similar in
VAT and SAT. Finally, the mean levels of methylation of
the genes of interest were similar in obese and slim
patients; however, the number of tissues from slimpatients was only 5 and the statistical power of this ana-
lysis was low.
Discussion
In this work we show that the mean expression of sev-
eral thermogenesis-related genes is significantly lower in
adipose tissues originating from obese patients than in
tissues from lean individuals. We also suggest that this
phenomenon is probably not associated with differential
methylation of their promoters.
The genes investigated in the present study formed
three groups. The first consisted of genes encoding β-
adrenergic receptors. Both ADRB2 and ADRB3 play an
important role in the regulation of lipolysis in human
BAT and WAT that provides free fatty acids for thermo-
genesis. There is indirect evidence that ADRB2 and
ADRB3 might participate in the regulation of body
weight in humans. For example, their established poly-
morphisms, e.g. Glu27 variant of ADRB2 or 64Arg vari-
ant of ADRB3, both characterized by a reduced receptor
activity were associated with metabolic complications
and with weight gain in different populations [23-26].
Individuals with a low ADRB3 function in adipose tissue
(assessed by its lipolytic activity) tend to increase their
body weight over time, whereas a high receptor function
seems to protect from weight gain [27]. These data, to-
gether with the results from animal studies showing that
mice with betaadrenergic receptors knock-outs have re-
duced metabolic rate and developed massive obesity due
to a failure of diet-induced thermogenesis [15] suggest
that an unaffected function of ADRB2 and ADRB3 is
crucial for thermogenesis and lipolysis in adipose tissue.
However, we found that the expression of ADRB2 and
ADRB3 encoding these receptors was significantly
decreased in adipose tissues of obese subjects. We
Figure 4 Correlation of the expression of ADRB2 (A), ADRB3 (B), DIO2 (C), THRA (D) and THRB (E) with the methylation status of their
promoters. Red dots represent samples with high whereas black – with low expression of the investigated gene.
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the development of obesity and speculate that this might
result in a lower effectiveness of receptor-stimulating
compounds in the treatment of this condition. Notably,
we did not observe differences in the ADRB1 expression
between obese and normal-weight study participants.
This finding is consistent with previous data showing no
association of polymorphic variants of this gene with
body mass in humans, and with the fact that the block-
age of ADRB1 did not inhibit cold-induced thermogen-
esis in humans [28].
The second analyzed group consisted of genes encod-
ing proteins involved in the metabolism (DIOs) and
function (TRs) of thyroid hormones, the most important
hormones involved in energy production in mitochon-
dria. Studies in animals have demonstrated that knock-
out of dio2 increased the susceptibility to diet-induced
obesity while animals with thra knockout were highly
vulnerable to low temperatures due to the complete lack
of BAT reactivity to noradrenergic stimulation [14,16].
Genetic studies performed in humans suggested that
functional polymorphisms of DIO2 and THRA that
decrease gene expression and/or protein activity might
increase susceptibility to obesity and its complications
[29,30]. Low expression of DIO2, THRA, and of THRB
in adipose tissues of obese individuals might then be a
mechanism related to the progression of obesity, difficul-
ties in weight loss and, supposedly, resistance to the
therapies targeting this pathway [31]. This hypothesis is
consistent with the finding that obese, clinically euthyr-
oid patients commonly have elevated serum levels of freeT3 (FT3) and decreased expression of THRA in adipose
tissues compared to lean individuals [32]. One can
therefore speculate that the reduced expression of THRA
and THRB in adipose tissue of obese individuals changes
the phenotype of adipocyte in such way that it becomes
partially “resistant” to T3. A decreased expression of
DIO2 resulting in a lower local conversion of T4 to T3
and a decreased intra-cellular concentration of T3 might
also contribute to this phenomenon. As a consequence,
the level of FT3 in serum increases to cope with the
peripheral hormone “resistance”, but this might be insuf-
ficient to normalize the disturbed T3-dependent metab-
olism in the adipocyte. Notably, we had expected that
DIO1, which is regulated by TRs, would be also under-
expressed in the obese, but our study did not confirm
these expectations. Moreover, Ortega et al. found that
the expression and activity of DIO1 are increased in adi-
pose tissues of obese individuals of Spanish origin [33],
suggesting a minor role for T3 in the regulation of DIO1
expression in adipose tissues of obese individuals.
The third group of analyzed genes was composed of
genes encoding uncoupling proteins. Since the expres-
sion of all of them is activated by T3 [11,34,35], one
could expect that in adipose tissues of obese subjects,
where the expression of THRA, THRB, and of DIO2 is
decreased, all UCP genes would be under-expressed. We
found however that only the expression of UCP2 was
decreased. Our data corroborate previous findings in
humans showing that obesity, low rates of energy ex-
penditure and metabolic complications are linked to cer-
tain UCP2 polymorphisms, such as the presence of 3′
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[36,37]. In turn, an unchanged expression of UCP1 and
UCP3 suggests that T3 might not be the most important
molecule controlling the activity of these genes in
adipose tissues of obese subjects. In fact, other, T3-
independent mechanisms may play a dominant role. In-
deed, some researchers suggest that a chief regulator of
UCP1 in adipose tissue is PPARγ coactivator-1α [38]. In
skeletal muscles, the UCP3 expression is up-regulated
when long-chain fatty acids delivery exceeds their oxida-
tion capacity and MyoD, PPARα and PPARδ transcrip-
tion factors co-regulate this process; it has not been
tested however if similar mechanisms regulate the UCP3
expression in adipocytes [39].
To date little is known about the differences in
thermogenic activity between VAT and SAT. The finding
that “beige” adipocytes are present predominantly in hu-
man SAT may suggest its dominant role in thermogenesis
[40] and support the epidemiological and experimental
data indicating that increased subcutaneous fat exerts a
lower risk of metabolic complications than visceral fat
reviewed in [41]. Our finding that the expression of DIO2,
ADRB2 and ADRB3 in obese subjects was significantly
lower in VAT than in SAT might indicate a lower lipolytic
and thermogenic potential of VAT, corroborating previous
studies.
Out of many mechanisms regulating gene expression
in adipose tissue, epigenetic modifications are of special
interest. Since diet is the chief factor influencing the
maturation and metabolism of adipocytes, as well as epi-
genetic modifications, especially methylation of DNA
[20-22,42], we decided to investigate if the changes re-
garding the expression of thermogenesis-related genes in
diet-induced obesity can be related to the methylation
status of their regulatory regions [43]. However, we
found no differences in methylation between normal-
weight and obese subjects, between VAT and SAT, and
between tissues with high vs. low expression of a given
gene. In addition, the methylation level of the investi-
gated genes was not related to the level of their expres-
sion. This may be due to a number of phenomena.
Firstly, methylation may not be the chief mechanism in-
volved in the regulation of activity of these genes in adi-
pose tissue. Secondly, the analyzed regions, although
carefully chosen, may not be crucial for the regulation of
gene activity. Thirdly, we have analyzed only the overall
methylation of the promoter fragments, while the differ-
ences in methylation of a specific cytosines located
within the binding sites for strong transcriptional activa-
tors could also be relevant. Therefore, further studies
using other analytical methods are needed to clarify
whether or not this epigenetic modification is involved
in the regulation of the activity of thermogenesis-related
genes in adipose tissue in obesity. In addition, newestdata indicate, that drugs often taken by obese individuals
can affect epigenetic modifications. For example, it has
been demonstrated that metformin might increase [44],
while statins might decrease methylation of DNA [45];
this should also be taken into account during data
analysis.Conclusions
To the best of our knowledge, the evidence we present
here is the first to show that adipose tissues of obese in-
dividuals are characterized by a decreased expression of
the key genes involved in the activation of thermogen-
esis. On that basis we propose that adipose tissue of
obese individuals might be less reactive to both hormo-
nal and adrenergic stimuli and, therefore, less likely to
activate thermogenesis than in lean subjects.Additional files
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